Lesson 18 • 29 Apr 2026
Combination Therapy Considerations and Trial Results
Course overview
This course explores the latest advancements in NMIBC diagnosis, surveillance, and therapy sequencing. Highlighting multidisciplinary strategies, emerging biomarkers, and real-world clinical insights for optimizing patient outcomes, gaining actionable knowledge to navigate evolving standards of care, and integrating innovative tools into their practice. Featuring Dr. Bogdana Schmidt, Dr. Piyush Agarwal, Dr. Anne Schuckman, Dr. Vignesh Packiam, Dr. Sarah Psutka, Dr. Katie Murray, Dr. Tyler Stewart, Dr. Mark Tyson, and Dr. Suzanne Merrill.
3 hours, 28 lessons
Lessons
Surveillance Strategies & Treatment Considerations
Lesson 1
Risk Stratification, Surveillance, and Diagnostics
Lesson 2
Imaging Protocols and Biomarker Strategies
Lesson 3
Blue Light Cystoscopy (BLC) and Cxbladder Applications
Lesson 4
Assessment and Considerations for Recurrence
Lesson 5
Predictive Tools and Selection of Intravesical Therapy
Lesson 6
Surveillance Strategies and Future Diagnostic Technologies
Advances in Bladder Cancer Monitoring & Therapy Guidance
Lesson 7
Evaluation Strategies: Diagnostic Tests and Biomarkers
Lesson 8
Biomarker Classifications and Utilization
Lesson 9
Molecular Subtyping and IHC Testing
Lesson 10
AI Integration: Clinical Workflow and Applications
Lesson 11
ctDNA and utDNA Roles and Future Directions
Lesson 12
Current Diagnostic Limitations and Advances for Surveillance
Lesson 13
Optimizing Assessment Strategies with Emerging Diagnostics in High-Risk Patients
Lesson 14
Implementing New Surveillance Strategies and Patient Impact
Multidisciplinary Perspective for NMIBC Management
Lesson 15
Collaborative Management Approaches and the Evolving Role of Medical Oncologists
Lesson 16
Neoaduvant Therapy Strategies for T1 and Variant Histologies
Lesson 17
Need for Game-Changing Biomarkers and Challenging the Bladder Preservation Bias
Lesson 18
Combination Therapy Considerations and Trial Results
Lesson 19
BCG Maintenance: Efficacy and Challenges
Lesson 20
Immunotherapy Adverse Events and Improving Patient Safety
Lesson 21
Checkpoint Inhibitors Management and Triage Resources
Sequencing Therapy & Treatment Strategies
Lesson 22
Clinical Considerations for BCG-Refractory Patients
Lesson 23
BCG Reinduction Algorithms and Navigating Shortages
Lesson 24
Cystectomy vs. Bladder Sparing Therapy
Lesson 25
Trial Data Review: Gene Therapy in BCG-Unresponsive Patients
Lesson 26
Analyzing Real-World Data and Trial Outcomes
Lesson 27
Clinical and Treatment Strategies in High-Risk and Recurrence Patients
Lesson 28
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.